Boston Scientific Corporation reported 19.3% y/y top-line growth in Q3 but faced margin deterioration, with operating margins dropping to 17.4% from 19.6% last year. The company projects 16.5% top ...

Coaptite was seen as the only traditional horizontal overlap between the two companies in their transaction, traders told Seeking Alpha on Wednesday. Axonics (AXNX) and Boston Scientific (BSX ...

Investors with a lot of money to spend have taken a bearish stance on Boston Scientific (NYSE:BSX). And retail traders should know. We noticed this today when the trades showed up on publicly ...

Boston Scientific (NYSE: BSX) is scheduled to report its Q3 2024 results on Wednesday, October 23. We expect the company to report revenues and earnings slightly below the consensus estimates.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(RTTNews) - While reporting financial results for the third quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and sales growth guidance for ...

Boston College, the first institution of higher education to operate in the city of Boston, is today among the nation’s foremost universities, a leader in the liberal arts, scientific inquiry, and ...

Has Boston Scientific (BSX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this ...